MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

The latest financial statement is for the year ending 2025-12-31.

Cash Flow Overview

Free Cash flow
-$82,954K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
    • Proceeds from sales and maturiti...
    • Net proceeds from sale of future...
    • Share-based compensation
    • Others
Negative Cash Flow Breakdown
    • Purchases of marketable securiti...
    • Net loss
    • Accounts receivable
    • Others

Cash Flow
2025-12-31
Net loss
-74,620
Depreciation and amortization
7,172
Amortization of premiums and discounts on marketable securities
1,648
Share-based compensation
14,286
Gain on royalty monetization arrangement
0
Gain on sale of margenza
0
Non-cash royalty revenue
7,932
Non-cash interest expense
8,259
Non-cash lease expense
1,784
Other non-cash items
0
(gain) loss on disposal of assets
10
Accounts receivable
9,063
Inventory
7,910
Prepaid expenses and other current assets
-2,769
Other non current assets
0
Accounts payable
-280
Accrued expenses and other current liabilities
-6,834
Lease liabilities
-699
Deferred revenue
-5,398
Other non current liabilities
-916
Net cash used in operating activities
-81,040
Purchases of marketable securities
208,336
Proceeds from sales and maturities of marketable securities
96,142
Purchases of property, equipment and software
1,914
Proceeds from sale of margenza
0
Proceeds from sales of equipment
11
Net cash provided by (used in) investing activities
-114,097
Proceeds from issuance of common stock, net of offering costs
0
Proceeds from stock option exercises and espp purchases
129
Taxes paid related to net share settlement of equity awards
288
Principal payments on royalty monetization arrangement
0
Net proceeds from sale of future royalties
69,673
Net cash provided by financing activities
69,514
Net change in cash and cash equivalents
-125,623
Cash and cash equivalents at beginning of period
182,840
Cash and cash equivalents at end of period
57,217
Unit: Thousand (K) dollars (except for numbers of shares and EPS).

Time Plot

Show the time plot by selecting a row from the table.

Cash Flow

Net proceeds fromsale of future...$69,673K Proceeds from stockoption exercises and...$129K Net cash provided byfinancing activities$69,514K Canceled cashflow$288K Net change in cashand cash...-$125,623K Canceled cashflow$69,514K Proceeds from sales andmaturities of marketable...$96,142K Proceeds from sales ofequipment$11K Share-based compensation$14,286K Non-cash interestexpense$8,259K Depreciation andamortization$7,172K Prepaid expenses andother current assets-$2,769K Non-cash lease expense$1,784K Taxes paid related tonet share...$288K Net cash provided by(used in) investing...-$114,097K Net cash used inoperating activities-$81,040K Canceled cashflow$96,153K Canceled cashflow$34,270K Purchases of marketablesecurities$208,336K Net loss-$74,620K Accounts receivable$9,063K Purchases of property,equipment and software$1,914K Non-cash royalty revenue$7,932K Inventory$7,910K Accrued expenses andother current...-$6,834K Deferred revenue-$5,398K Amortization of premiums anddiscounts on marketable...$1,648K Other non currentliabilities-$916K Lease liabilities-$699K Accounts payable-$280K (gain) loss on disposalof assets$10K

MACROGENICS INC (MGNX)

MACROGENICS INC (MGNX)